CIBMTR

Trustworthy transplant research—now easier to find. Explore Study Summaries organized by disease and condition: lymphoma, multiple myeloma, sickle cell disease, and more. Start exploring ➡️cibmtr.org/summaries

Our study summaries page just got a major upgrade! Search by category, find what you need faster, and browse clear, plain‑language summaries. Explore the new layout ➡️ cibmtr.org/summaries

Today at #EBMT26: Hear about outcomes from the NMDP-sponsored ACCESS trial:

Live at #EBMT26 today: CIBMTR oral and poster abstracts! Take a look:

Excellent session with presidents from different regions of the world discussing donor selection in hematopoietic stem cell transplantation, highlighting both global similarities and regional differences.@TheEBMT

📊 EBMT is here—and so is your chance to meet the expert physicians behind the groundbreaking NMDP/@CIBMTR data‼️ 📍 Stop by Booth 41 to chat with Dr. Steven Devine and Dr. Jeffrey Auletta. Bring your questions. Review the data. Continue the discussion.

Excellent session on donor selection and germline mutations. An important and evolving challenge in allogeneic transplantation, highlighting how inherited predisposition may significantly influence donor choice and long-term outcomes. #EBMT2026 #HSCT #Hematology

📢 Now Hiring: Program Director I – Statistical Operations (CIBMTR) Lead biostatistics teams and collaborate with medical & scientific researchers across the full research lifecycle, advancing high‑impact BMT research. 🔗 Apply: mcw.wd503.myworkdayjobs.com/ExternalCareer… #Hiring #Biostatistics

Attending #EBMT26? Make sure to check out these abstracts today. Don’t miss these oral and poster abstracts!

#EBMT26 begins today! Here’s the full schedule of CIBMTR abstracts being presented this week.

Coming soon to #EBMT26: CIBMTR will present a variety of oral and poster abstracts. Here’s a quick overview of when this research will be featured throughout the meeting.

New tool predicts acute graft-vs-host disease after transplant. Read about this CIBMTR study to learn more: cibmtr.org/Patient-Summar…

We're gearing up for #Tandem27 in Orlando, Florida! Tune in for registration dates, abstract submissions, and more as they become available in Tandem Meeting News:tandemmeetingsnews.com/save-the-date-…

Combinational therapies, engineered cells, off-the-shelf allogeneic projects, and in vivo cell programming may define the next era of progress, according to Stephen Gottschalk, MD. Read more about this session in Tandem Meeting News: tandemmeetingsnews.com/expert-reviews…

Beyond the bench and bedside, social workers at #Tandem26 shared key insights for addressing barriers tied to social determinants of health. Find out more about this session in Tandem Meeting News: tandemmeetingsnews.com/social-workers…

What challenges arise when applying artificial intelligence to cellular therapy? Experts explore the answers and more in this #Tandem26 APP Track Session. Read more in Tandem Meeting News: tandemmeetingsnews.com/panel-examines…

At #Tandem26, Michael J. Eckrich, MD, MPH, challenged attendees to prioritize patients and training to bring advances in gene editing into the clinic. Get the details in Tandem Meeting News: tandemmeetingsnews.com/expert-shares-…

CHARM predicts who may need extra care after transplant. Read about this CIBMTR study to learn more: cibmtr.org/Patient-Summar…

Jump back into abstracts from #Tandem26 with authors like Saurabh Dahiya, MD, FACP, who shared results from the first-in-human study of KITE-753 and KITE-363—one of six author presentations that can be read about in Tandem Meeting News: tandemmeetingsnews.com/oral-abstract-…

People with sickle cell trait can safely donate bone marrow. Read about this CIBMTR study to learn more: cibmtr.org/Patient-Summar…